TdC 261: Fibrilação atrial - Condutas no pronto-socorro

Notas do episódio

https://www.tadeclinicagem.com.br/guia/ Confira a promoção especial para o plano anual do Guia TdC: Receba em casa o Card de Consulta Rápida no Plantão, com os temas: IOT, ACLS, ATB, ECG, trombólise e reposição eletrolítica. Receba em casa o porta-crachá (tirante para crachá) do TdC. Ganhe R$ 50 OFF (de 449 por 399,00) 7 primeiros dias inteiramente grátis Use o CUPOM: GUIADZERO 🚨 www.tadeclinicagem.com.br/guia - Conheça o Guia TdC com 7 dias grátis 🚨 Kaue Malpighi e Lucca Cirillo convidam Rafael Martins (@ecg_aulas) para conversar sobre manejo de fibrilação atrial no PS. Referências: 1. Andrade, Jason G, and L Brent Mitchell. “Periprocedural Anticoagulation for Cardioversion of Acute Onset Atrial Fibrillation and Flutter: Evidence Base for Current Guidelines.” The Canadian journal of cardiology vol. 35,10 (2019): 1301-1310. doi:10.1016/j.cjca.2019.06.006 2. Palomäki, A., Mustonen, P., Hartikainen, J. E. K., Nuotio, I., Kiviniemi, T., Ylitalo, A., Hartikainen, P., Lehtola, H., Luite, R., & Airaksinen, K. E. J. (2016). Strokes after cardioversion of atrial fibrillation - The FibStroke study. International Journal of Cardiology, 203, 269–273. https://doi.org/10.1016/j.ijcard.2015.10.168 3. Joglar, José A et al. “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.” Circulation vol. 149,1 (2024): e1-e156. doi:10.1161/CIR.0000000000001193 4. Moran JL, Gallagher J, Peake SL, et al. Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study. Crit Care Med. 1995 Nov;23(11):1816-24. doi: 10.1097/00003246-199511000-00005 5. Slavik RS, Tisdale JE, Borzak S. Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence. Prog Cardiovasc Dis. 2001 Sep-Oct;44(2):121-52. doi: 10.1053/pcad.2001.26966 6. Davey MJ, Teubner D. A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation. Ann Emerg Med. 2005 Apr;45(4):347-53. doi: 10.1016/j.annemergmed.2004.09.013 7. Van Gelder IC, Groenveld HF, Crijns HJ, et al.; RACE II Investigators. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010 Apr 15;362(15):1363-73. doi: 10.1056/NEJMoa1001337 8. Wetterslev M, Haase N, Hassager C, et al. New-onset atrial fibrillation in adult critically ill patients: a scoping review. Intensive Care Med. 2019 Jul;45(7):928-938. doi: 10.1007/s00134-019-05633-x 9. O'Bryan LJ, Redfern OC, Bedford J, et al. Managing new-onset atrial fibrillation in critically ill patients: a systematic narrative review. BMJ Open. 2020 Mar 24;10(3):e034774. doi: 10.1136/bmjopen-2019-034774 10. Kirchhof P, Camm AJ, Goette A, et al. EAST-AFNET 4 Trial Investigators. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422